• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

United Kingdom

new york stock exchange
Pharma

AstraZeneca plots NYSE listing amid UK industry pullback

The move will replace AZ’s existing U.S. listing of American Depositary Receipts on the Nasdaq, which simplify U.S. investing in foreign companies.
Fraiser Kansteiner Sep 29, 2025 10:05am
Moderna

Moderna crowns new UK facility as other pharmas pile on Britain

Sep 25, 2025 9:55am
UK USA US

UK needs to adjust investment evaluation model, ABPI says

Sep 3, 2025 11:40am
pause button on blue background

Lilly pauses UK orders on its diabetes and obesity med Mounjaro

Aug 28, 2025 11:08am
Pound

UK pharma drug price talks reach impasse

Aug 22, 2025 10:50am
Britain Big Ben United Kingdom London

PMCPA slams Theramex for 'wholly unacceptable' compliance issues

Jul 22, 2025 10:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings